SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Cigna Corp.

NEW YORK--()--Levi & Korsinsky announces it has commenced an investigation of Cigna Corp. (“Cigna” or the “Company”) (NYSE: CI) concerning possible violations of federal securities laws by certain officers and directors.

The investigation concerns the Company’s January 22, 2016, disclosure that it had received an enforcement letter from the Department of Health & Human Services Centers for Medicare & Medicare Services (“CMS”), citing noncompliant appeals and grievances procedures within the Company dating back to at least 2013. In addition, CMS has imposed sanctions on the Company by suspending the enrollment of and marketing to new customers of all Cigna Medicare Advantage and Standalone Prescription Drug Plan Contracts. To obtain additional information about the investigation, go to:

http://zlk.9nl.com/cigna

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Release Summary

Levi & Korsinsky announces it has commenced an investigation of Cigna Corp. concerning possible violations of federal securities laws

Contacts

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com